A month has gone by since the last earnings report for Vertex Pharmaceuticals (VRTX). Shares have added about 7.3% in that time frame, outperforming the S&P 500. Will the recent positive trend ...

Parnassus Investments, an investment management company, released the “Parnassus Core Equity Fund” fourth quarter 2024 ...

Alongside this dynamic new model, Google also unveiled ShieldGemma 2. In a push for responsible AI image generation, ...

About the company: SurgeGraph Vertex is an SEO AI writing tool with a mission to redefine content writing through humanized, ...

Google has released four new open-source AI models under the Gemma 3 series, which are tailor-made for deploying on mobile platform and beat OpenAI while at it.

Representative Jefferson Shreve (R-Indiana) recently bought shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). In a filing disclosed on March 09th, the Representative disclosed that they had ...

We provide more details on some of the top companies in the Nasdaq 100 index that are dragging the QQQ ETF this year.

Vertex Pharmaceuticals has dominated the cystic fibrosis (CF) market and is now expanding into new, high-growth areas. The ...

The US pharmaceutical sector is experiencing a distinct trend never seen before with large American pharma companies continually looking for medicines in China.

KING OF PRUSSIA, Pa., March 11, 2025 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ: VERX) today announced that it will host an Investor Day on Wednesday, March 19, in Philadelphia, PA. The event will ...

The cell-based product is a nicotinamide modified allogeneic hematopoietic progenitor cell therapy that was FDA-OK'd and launched in 2023.

Taking care of my personal health remains a top priority, however, I have also turned my attention to encouraging others to prioritize their health by raising awareness of my experiences. I understand ...